Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-20-006527
Filing Date
2020-11-13
Accepted
2020-11-13 16:45:34
Documents
45
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q celz_10q.htm 10-Q 399309
2 CERTIFICATION celz_ex311.htm EX-31.1 10980
3 CERTIFICATION celz_ex312.htm EX-31.2 10551
4 CERTIFICATION celz_ex321.htm EX-32.1 4280
5 CERTIFICATION celz_ex322.htm EX-32.2 4482
  Complete submission text file 0001477932-20-006527.txt   2195668

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT celz-20200930.xml EX-101.INS 298744
7 XBRL TAXONOMY EXTENSION SCHEMA celz-20200930.xsd EX-101.SCH 30063
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE celz-20200930_lab.xml EX-101.LAB 193851
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE celz-20200930_cal.xml EX-101.CAL 32191
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celz-20200930_pre.xml EX-101.PRE 175715
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celz-20200930_def.xml EX-101.DEF 118820
Mailing Address 211 E. OSBORN RD. PHOENIX AZ 85012
Business Address 211 E. OSBORN RD. PHOENIX AZ 85012 833-336-7636
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001187953 (see all company filings)

EIN.: 870622284 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53500 | Film No.: 201312174
SIC: 2836 Biological Products, (No Diagnostic Substances)